Article Text

PDF
Letters
NICE, drug-eluting stents and the limits of trial data
  1. R Mohindra
  1. Dr R Mohindra, 63 Newlands Road, Newcastle upon Tyne NE2 3NT, UK; raj.mohindra1{at}googlemail.com

Statistics from Altmetric.com

To the editor: Dr de Belder asks the question how to determine the worth of drug-eluting stents?1 The answer to this question does not lie in the trial data. The function of trial data is to establish the extent of clinical-effectiveness to a given degree of certainty. In this context, while a trend may generate a hypothesis it does not establish clinical-effectiveness.

There is no balance between clinical- …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Featured correspondence
    A Esposito F De Cobelli G Perseghin A Del Maschio
  • Featured correspondence
    M A de Belder